Agilent
JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More
Highlights of the second day included Labcorp's update on its COVID-19 testing trends and Ortho Clinical's perspective on its proposed acquisition by Quidel.Â
Agilent Q4 Revenues Rise 12 Percent
Revenues for the diagnostics and genomics group increased 16 percent to $341 million from $294 million in the year-ago quarter.
In Brief This Week: PerkinElmer, Labcorp, Illumina, Thermo Fisher Scientific, and More
News items for the in vitro diagnostics industry for the week of Nov. 15, 2021.
Agilent Gets CE Mark for Expanded Use of PD-L1 CDx in Triple-Negative Breast Cancer
The CDx, developed by Agilent and Merck, can now be used as an aid in identifying triple-negative breast cancer patients for treatment with pembrolizumab in the European Union.
Agilent Obtains CE Mark for CDx to Guide Treatment With Immunotherapeutic Agent Opdivo
The CDx guides options for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal cancers.
Aug 17, 2021
Agilent Technologies Q3 Revenues Rise 26 Percent
May 25, 2021
Agilent Q2 Revenues Rise 23 Percent
Apr 14, 2021
Mar 9, 2021
Agilent Receives CE Mark for SARS-CoV-2 PCR Test
Mar 4, 2021
Mar 4, 2021
Agilent Prices $850M Senior Notes Offering
Feb 24, 2021